Reuters logo
10 个月前
BRIEF-Reata Pharmaceuticals says data from catalyst are expected to be available during first half of 2018
2016年10月6日 / 下午1点42分 / 10 个月前

BRIEF-Reata Pharmaceuticals says data from catalyst are expected to be available during first half of 2018

1 分钟阅读

Oct 6 (Reuters) - Reata Pharmaceuticals Inc :

* PAH patients and reports positive interim data from CTD-PAH patients in phase 2 lariat trial

* Data from catalyst are expected to be available during first half of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below